FDA Final Tracking Guidance Specifies Three Criteria For Issuing Orders
This article was originally published in The Gray Sheet
Executive Summary
FDA will consider the "likelihood of sudden, catastrophic failure" as one of three factors used to decide whether to issue tracking orders for a particular type of device, according to a revised final guidance document on device tracking released Feb. 12.
You may also be interested in...
Device tracking
Abdominal aortic aneurysm stent grafts are added to the list of devices that require tracking in revised final guidance that supersedes guidance issued Feb. 19 (1"The Gray Sheet" Feb. 15, p. 11). Tracking orders for the stent grafts were issued Sept. 28. Other revisions clarify that tracking is only required for infusion pumps that are electromechanical and heart valves that are mechanical
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.